Bronson Crouch
Förmögenhet: 903 478 $ per 2026-07-31
Förmögenhet: 903 478 $ per 2026-07-31
Bronson Crouch is Chairman & Chief Executive Officer at Instil Bio, Inc. since 2018.
Mr. Crouch is Managing Partner at Peloton Therapeutics, Inc. and TCR² Therapeutics, Inc. Mr. Crouch is Founding Partner at Curative Ventures Management LLC since 2014.
Former roles include Managing Partner at CoStim Pharmaceuticals, Inc. and Managing Partner at iTeos Therapeutics, Inc.
| Företag | Datum | Antal aktier | Värdering | Värderingsdatum |
|---|---|---|---|---|
INSTIL BIO, INC. 1,87 % | 2026-04-13 | 126 893 ( 1,87 % ) | 903 478 $ | 2026-07-31 |
| Företag | Position | Start |
|---|---|---|
| INSTIL BIO, INC. | Verkställande Direktör | 2018-11-01 |
| TCR2 THERAPEUTICS INC. | Företagsledare/Principal | - |
| PELOTON THERAPEUTICS, INC. | Företagsledare/Principal | - |
Curative Ventures Management LLC
Curative Ventures Management LLC Investment ManagersFinance Curative Ventures invests in companies located in the United States. The firm targets companies operating in the fields of healthcare technologies sector. It provides financing for early stage capital requirements | Privat kapitalinvesterare | 2014-01-01 |
| Företag | Position | Slut |
|---|---|---|
| ITEOS THERAPEUTICS, INC. | Företagsledare/Principal | - |
CoStim Pharmaceuticals, Inc.
CoStim Pharmaceuticals, Inc. BiotechnologyHealth Technology Operates as a biotech company which develops biologics for oncology indications | Företagsledare/Principal | - |
Aktiva
Inaktiva
Börsnoterade företag
Privata företag
Första gradens relationer
Företag kopplade till första graden
Man
Kvinna
Styrelseledamöter
Chefer
| Privata företag | 6 |
|---|---|
Peloton Therapeutics, Inc.
Peloton Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company which engages in developing and researching drugs for cancer patients | Health Technology |
CoStim Pharmaceuticals, Inc.
CoStim Pharmaceuticals, Inc. BiotechnologyHealth Technology Operates as a biotech company which develops biologics for oncology indications | Health Technology |
TCR2 Therapeutics, Inc.
TCR2 Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage cell therapy company which engages in the development of biological drugs and engineering T-cells for cancer therapy | Health Technology |
Curative Ventures Management LLC
Curative Ventures Management LLC Investment ManagersFinance Curative Ventures invests in companies located in the United States. The firm targets companies operating in the fields of healthcare technologies sector. It provides financing for early stage capital requirements | Finance |
Instil Bio, Inc.
Instil Bio, Inc. BiotechnologyHealth Technology Develops tumour infiltrating lymphocytes for the treatment of cancer | Health Technology |
iTeos Therapeutics, Inc.
iTeos Therapeutics, Inc. BiotechnologyHealth Technology Develops immunomodulators for cancer treatments | Health Technology |
Välj din utgåva
All finansiell information anpassad till den nationella nivån